Michael T Yin, MD

Infectious Disease
Accepting New Patients
Profile Headshot


Dr. Yin is an Associate Professor of Medicine in the Division of Infectious Diseases.

Areas of Expertise / Conditions Treated

  • HIV Infection
  • HIV Medicine

Academic Appointments

  • Associate Professor of Medicine

Administrative Titles

  • Associate Fellowship Program Director

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Allen Hospital


  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In


180 Fort Washington Avenue
Suite 2-242
New York, NY 10032

Insurance Accepted

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care


  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs


  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO


  • Medicare Managed Care
  • PPO


  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care


  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare


  • Railroad
  • Traditional Medicare


  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management


  • Special Needs


  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO


  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Infectious Disease

Honors & Awards

2011 Irving Scholars Award

2015 Harold and Golden Lamport Award for Excellence in Clinical Science Research

2017 Ewig Clinical Scholar Award for Clinical Education


Dr. Michael Yin is an infectious disease specialist who has dedicated his career towards optimizing HIV treatment and prevention. His research focuses upon non-infectious complications of HIV which is growing in significance as people with HIV live longer with effective antiretrovirals therapy (ART) and experience accentuated aging-related complications. He has evaluated the epidemiology and pathogenic mechanisms of HIV associated bone loss in postmenopausal women, adolescents, and children with perinatal infection. Using novel imaging techniques and translational bone cell assays, he has made important discoveries about the dysregulation of bone metabolism associated with HIV infection and ART and investigated therapeutic strategies to mitigate bone loss and fracture. In addition to skeletal complications, Dr. Yin has also studied the impact of HIV and ART on cardiovascular disease, metabolic syndrome, obesity, frailty and falls. Recent work has extended to evaluation of epigenetic aging in children, adolescents and adults living with HIV.

Much of Dr. Yin’s research builds upon interdisciplinary collaborations within HIV networks. He is an active, investigator in AIDS Clinical Trials Group (ACTG) and the Combined Cohort Study (MACS/WIHS). Dr. Yin has also led studies to engage hard to reach populations both for HIV prevention and treatment, using combinations of behavioral, structural and biomedical strategies. These multidisciplinary efforts have relied upon collaboration with colleagues with expertise in behavioral science, implementation science and biomedical informatics. He is the Co-Director the Biobehavioral Core of the HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University. His team has also been immersed in COVID-19 research and established a longitudinal cohort, the COVID-19 Persistence ID Cohort (C-PIC), to study viral dynamics, evolution of antibody response and the post-acute sequelae of SARS-CoV-2 (PASC) in collaboration with researchers at the Aaron Diamond AIDS Research Center (ADARC).

Research Interests

  • HIV therapy and metabolic complications

Selected Publications

  1. Peters B, Hanna D, Sharma A, Anastos K, Hoover DR, Shi Q, Moran C, Jackson E, Alcaide M, Ofotokun I, Adimora A, Haberlan S, Cohen M, Tien P, Michel K, Levine S, Hodis H, Kaplan R, Yin MT. Menopausal hormone therapy and subclinical cardiovascular disease in women with and without HIV. Clinical infectious Diseases 2022; PMID:35903868.
  2. Yin MT, Hoover DR, Shi Q, Tien PC, Cohen MH, Kassaye S, Gustafson D, Adimora A, Weitzmann MN, Bolivar H, Warriner A, Bares BH, Sharma A. Hormone therapy and fractures in postmenopausal women. AIDS 2022; PMID: 35730385.
  3. Liu L, Meyers K, Purpura LJ, Nguyen N, Mohri H, Chang JY, Annavajhala MK, Lopez L, Lee SW, Shah J, Lane B, Cantos A, Tukuru SA, Guo Y, Ford K, Chiu YT, Sheng Z, Choesang T, Castor D, Wang M, Pili C, Van Hoy MN, Wallach A, Horton J, Chen Z, Rosenthal S, McLaren S, Jiang B, Wang F, Lu H, Uhlemann AC, Ho DD, Yin MT. Development and performance of a point-of-care rapid antigen test for detection of SARS-CoV-2 variants. Journal of Clinical Virology Plus 2022; August 2(3): 100080. PMID: 35528048.
  4. Wadhwa S, Dave S, Daily ML, Nardone A, Li R, Rosario J, Cantos A, Shah J, Lu HH, McMahon DJ, Yin MT. The role of oral health in the acquisition and severity of SARS-CoV-2: A retrospective chart review. Saudi Dental Journal 2022; PMID: 35974970.
  5. Kyzar E, Purpura LJ, Shah J, Cantos A, Nordvig AS, Yin MT. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain, Behavior, & Immunity-Health 2021; 16:100315 PMID: 34345869.
  6. Laracy J, Zucker J, Castor D, McMahon DJ, Guo TW, Yan M, Shalev N, Scherer M, Gordon P, Sobieszczyk M, Yin MT. HIV-1 infection does not change disease course or inflammatory pattern of SARS-CoV2 infected patients presenting at a large urban medical center in New York City. Open Forum Infectious Diseases 2021; 8(2): ofab029. PMID: 33604406
  7. Sharma A, Hoover DR, Shi Q, Tien PC, Weber KM, Shah JG, Yin, MT. HIV and Menopause are Independently Associated with Lower Bone Mineral Density: Results from the Women's Interagency HIV Study. Clinical Infectious Diseases 2021; PMID: 345955517.
  8. Shiau S, Cantos A, Vivar Ramon C, Shen Y, Shah J, Jang G, Baccarelli AA, Arpadi SM, Yin MT. Epigenetic age in young African American adults with perinatally-acquired HIV. JAIDS 2021; 87(4): 1102-1109. PMID: 33765682.
  9. Shiau S, Shen Y, Cantos A, Vivar Ramon C, Shah J, Jang G, Mann JJ, Brickman AM, Baccarelli AA, Arpadi SM, Yin MT. Epigenetic aging biomarkers associated with cognitive impairment in older African American adults with HIV. Clinical Infectious Diseases 2021; 73(11):1982-1991. PMID:34143869.
  10. Yin MT, Bucovsky M, Williams J, Brunjes D, RoyChoudhury A, Colon I, Ferris DC, Olender S, Schulze C, Sharma A, Zeana C, Zingman B, Shane E. Effect of Vitamin D3 and calcium carbonate supplementation on muscle strength in postmenopausal women living with HIV, Antiviral Therapy 2020; 25(8):411-418. PMID:33705355.
  11. Ross R, Sharma A, Shi Q, Hoover DR, Weber KM, Tien PC, French AL, Al-Harthi L, Yin MT. Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus. Bone Reports 2020, 12:100279. PMID 3245512
  12. Mootz J, Evans H, Tocco J, Vivar-Ramon C, Gordon P, Yin MT. Acceptability of Electronic Healthcare Predictive Analytics for HIV Prevention: A Qualitative Study with MSM in New York City. Mhealth 2019, doi: 10.21037/mhealth.2019.10.03 PMID: 32270003.
  13. Sharma A, Hoover DR, Shi Q, Gustafson DR, Plankey MW, Tien PC, Weber KM, Yin MT. Frailty as a Predictor of Falls in HIV-infected and Uninfected Women. Antiviral Therapy 2019; 24(1):51-56. PMID: 30531305.
  14. Sharma A, Shi Q, Hoover DR, Tien PC, Plankey MW, Cohen MH, Golub ET, Gustafson D, Yin MT. Frailty predicts fractures among women with and at-risk for HIV: results from the Women’s Interagency HIV Study. AIDS 2019; 33(3):55-463. PMID 30702514.
  15. Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B, Shane E. A randomized placebo-controlled trial of low versus moderate dose Vitamin D3 supplementation on bone mineral density in postmenopausal women with HIV. Journal of Acquired Immune Deficiency Syndrome, 2019; 80(3):342-349. PMID: 30531305 PMCID: PMC 30531305
  16. Hsieh E, Shiau S, Nolan O, Gibert CL, Bedimo RJ, Rodriguez-Barradas C, Justice AC, Womack JA, Yin MT. Increased fragility fracture rates in older men with osteomyelitis. Clinical Infectious Diseases 2019. 69(7):1239-1242. PMID 30715288.
  17. Yang J, Sharma A, Shi Q, Anastos K, Cohen MH, Golub ET, Gustafson D, Merenstein D, Mack WJ, Tien PC, Nieves J, Yin MT. Improved fracture prediction using different FRAX adjustments in HIV-infected women. AIDS 2018, 32(12):1699-1706. PMID:29762165.
  18. Sharma A, Ma Y, Tien PC, Scherzer R, Anastos A, Cohen MH, Hans D, Yin MT. HIV Infection is Associated with Abnormal Bone Microarchitecture: Measurement of Trabecular Bone Score in the Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndrome. 2018, 78(4):441-449. PMID: 29940603.
  19. Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Tenorio A, Melbourne K, Napoli A, Ribaudo HJ, Yin MT. High-dose vitamin D and calcium attenuates bone loss with antiretroviral therapy initiation: a prospective, randomized placebo-controlled trial for bone health in HIV-infected individuals. Annals of Internal Medicine 2015;162(12):815-824. PMID: 26075752 PMCID: PMC4608553
  20. Manavalan JS, Apradi S, Tharmarajah S, Shah J, Zhang CA, Foca M, Neu N, Bell DL, Nishiyama K, Kousteni S, Yin MT. Abnormal bone acquisition with early-life HIV infection: role of immune activation and senescent osteogenic precursors. Journal of Bone and Mineral Research 2016, 31(11):1988-1996. PMID: 27283956